Koyfin Home > Directory > Health Care > Becton Dickinson and Company > Capital Expenditures

Becton Dickinson and Company Capital Expenditures Chart (BDX)

Becton Dickinson and Company annual/quarterly Capital Expenditures from 2010 to 2020.
  • Becton Dickinson and Company Capital Expenditures for the quarter ending September 09, 2020 was $-213m a 18.78% decrease of -40m year over year
  • Becton Dickinson and Company Capital Expenditures for the last 12 months ending September 09, 2020 was $-810m a -18.89% increase of 153m year over year
  • Becton Dickinson and Company Annual Capital Expenditures for 2020 was $-810m a -18.15% increase of 147m from 2019
  • Becton Dickinson and Company Annual Capital Expenditures for 2019 was $-957m a 6.48% decrease of -62m from 2018
  • Becton Dickinson and Company Annual Capital Expenditures for 2018 was $-895m a 18.77% decrease of -168m from 2017
Other Cash Flow Metrics:
  • Becton Dickinson and Company Cash Flow from Operations for the quarter ending December 12, 2018 was $245m a -184.49% decrease of -452m year over year
  • Becton Dickinson and Company Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $437m a -80.17% decrease of -350m year over year
  • Becton Dickinson and Company Total Revenue for the quarter ending December 12, 2018 was $4,160m a -1.49% decrease of -62m year over year
View Chart On Koyfin

Quarterly BDX Capital Expenditures Data

09/2020$-213m
06/2020$-202m
03/2020$-222m
12/2019$-173m
09/2019$-358m
06/2019$-237m
03/2019$-195m
12/2018$-167m
09/2018$-307m
06/2018$-197m

Annual BDX Capital Expenditures Data

2020$-810m
2019$-957m
2018$-895m
2017$-727m
2016$-693m
2015$-596m
2014$-592m
2013$-522m
2012$-487m
2011$-509m